메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kwak Yee Gyung (Department of Internal Medicine Inje University Ilsan Paik Hospital Goyang Korea.) Song Je Eun (Department of Internal Medicine Inje University Ilsan Paik Hospital Goyang Korea.) Kang Jieun (Department of Internal Medicine Inje University Ilsan Paik Hospital Goyang Korea.) Kang Jiyeon (Department of Internal Medicine Inje University Ilsan Paik Hospital Goyang Korea.) Kang Hyung Koo (Department of Internal Medicine Inje University Ilsan Paik Hospital Goyang Korea.) Koo Hyeon-Kyoung (Department of Internal Medicine Inje University Ilsan Paik Hospital Goyang Korea.) Park Hye Kyeong (Department of Internal Medicine Inje University Ilsan Paik Hospital Goyang Korea.) Choi Sang Bong (Department of Internal Medicine Inje University Sanggye Paik Hospital Seoul Korea.) Lee Hyuk Pyo (Department of Internal Medicine Inje University Sanggye Paik Hospital Seoul Korea.) Lee Myung Jin (Department of Internal Medicine Inje University Sanggye Paik Hospital Seoul Korea.) Kim Baek-Nam (Department of Internal Medicine Inje University Sanggye Paik Hospital Seoul Korea.)
저널정보
대한감염학회 Infection and Chemotherapy Infection and Chemotherapy 제54권 제4호
발행연도
2022.12
수록면
781 - 786 (6page)
DOI
10.3947/ic.2022.0103

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Regdanvimab is the only monoclonal antibody available in Korea that targets severe acute respiratory syndrome coronavirus 2. We retrospectively evaluated the clinical characteristics of 374 adults hospitalized with coronavirus disease 2019 (COVID-19) who were treated with regdanvimab from September through December 2021. In total, 322 (86.1%) patients exhibited risk factors for disease progression. Most patients (91.4%) improved without additional treatment. No patient died or was transferred to intensive care. This study shows that regdanvimab prevented disease progression in high-risk patients with mild to moderate COVID-19 infections during Delta variant predominance.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0